← Back to Search

Procedure

CO2 Laser Ablation for Vulvar Intraepithelial Neoplasia

N/A

Waitlist Available

Led By Saketh Guntupalli, MD

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial is looking at whether laser ablation or ultrasonic aspiration is more effective in treating vulva dysplasia.

Eligible Conditions

Vulvar Intraepithelial Neoplasia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Participants With Recurrence of Dysplasia

Secondary outcome measures

Changes in Mental and Physical Wellness

Changes in Sexual Function

Number of Participants With Scarring

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CO2 Laser AblationExperimental Treatment1 Intervention

Treatment of VIN dysplasia with CO2 Laser Ablation: to evaluate the incident of recurrence of VIN dysplasia events in women treated for VIN with the sonopet ultrasonic aspirator compared to CO2 Laser Ablation

Group II: Sonopet Ultrasonic AspiratorActive Control1 Intervention

Treatment of VIN dysplasia with sonopet ultrasonic aspirator: to evaluate the incident of recurrence of VIN dysplasia events in women treated for VIN with the sonopet ultrasonic aspirator compared to CO2 Laser Ablation

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CO2 Laser Ablation

2017

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,737 Previous Clinical Trials

2,149,259 Total Patients Enrolled

Stryker InstrumentsIndustry Sponsor

14 Previous Clinical Trials

1,347 Total Patients Enrolled

Saketh Guntupalli, MDPrincipal InvestigatorUniversity of Colorado, Denver

2 Previous Clinical Trials

499 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still availability for patients to participate in this clinical experiment?

"As indicated on clinicaltrials.gov, this scientific study is no longer actively seeking participants; the original posting was made in March 2017 and it has been up-to-date as recently as June 2022. Nevertheless, there are over two thousand other trials presently recruiting candidates."

Answered by AI

Is this clinical research open to individuals aged 35 or above?

"To be eligible for this research initiative, participants must fall between 18 and 89 years of age. This trial has 303 studies specifically targeting minors, as well as 2269 trials dedicated to those aged 65 or above."

Answered by AI

Who qualifies to join this clinical trial?

"To qualify for this clinical investigation, applicants must be diagnosed with carcinoma in situ and fall between 18-89 years of age. Altogether, the trial is attempting to recruit 150 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia

2017. "Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02875561.